Mr
Michael
Nelson

Partner & European and UK Patent Attorney

Basel Office

Chemistry

Telephone. +41(0) 61 225 4480
Mobile. +41(0) 78 698 8690
Email. [email protected]
Vcard
Linkedin

Experience

Michael is a specialist patent attorney in the in the pharmaceutical field and has more than 20 years of experience at all stages of a product, from early phase discovery to defending marketed pharmaceutical products. Michael acts for a wide range of clients including multinationals, SMEs, universities and research organisations.

Prior to joining HGF Michael worked "in-house" as a patent attorney for 13 years for AstraZeneca and use this experience and insight to advise clients and develop IP strategies that are focused on their commercial objectives.

His work covers patent drafting, global prosecution, patent term extensions and SPCs, freedom to operate analysis and opinions, regulatory exclusivity as well as significant experience in IP due diligence evaluation. Michael also handles EPO oppositions and appeals for his clients.

Specialisms

Industries

Services

Qualifications

Patent Attorney

Chartered (UK)
European

BSC

Physics (First Class Honours)

Publications

Opposition case studies

View publication online

Swiss Institute for Translational and Entrepreneurial Medicine

View publication online

Conferences: 2022

June 27th 2022

Webinar: A comparison of IP Practice in EU, US and JP for new medical use and method of treatment patenting

Speaker

Event details

Conferences: 2021

May 10th 2021

Intellectual Property - Are you protecting your business ideas?

Speaker

Event details

Conferences: 2020

March 3rd 2020

IP in Healthcare Conference 2020

Speaker

Event details

Conferences: 2019

June 27th 2019

Update on the CRISPR IP Saga and lessons to be learnt - Basel

Speaker

Event details

March 14th 2019

IP in Healthcare Conference 2019 - London & Manchester

Speaker

Event details

Related News

Can AI replace patent attorneys?

OpenAI recently released a dialogue-based AI chatbot called ChatGPT, which is free for anyone to try out. You can try it here (https://chat.openai.com/chat). It’s been shown that it can set, …

Read article
Event - 29th November 2022

LSPN Europe 2022

HGF is a silver sponsor of LSPN Europe 2022 on 29th November in London. This event will explore some of the biggest challenges facing the Life Sciences Patent Community right now …

Event details
Event - 9th December 2022

Health Tech Conference 2022

HGF is a premium sponsor of the pro-manchester Health Tech conference on Friday 9th December. This conference looks at exploring what new and innovative ideas have been developed in the …

Event details

Changes to the procedure for remedying patent applications at the EPO

From 1 November 2022, the EPO has announced changes to the procedure for remedying patent applications that contain parts that have been included erroneously and updated the procedure for filing …

Read article
Event - 30th-1st December 2022

IAM Connect UPC 2022

HGF is a gold sponsor at the IAM Connect UPC 2022. This is an online event conducted over Zoom on the 30th November – 1st December. This event will allow leading …

Event details
Event - 10th November 2022

Webinar: basics and news about Unified Patent Court

HGF is hosting a webinar on 10th November to discuss ‘Basics and news about Unified Patent Court’. Date 10th November, 2022 Time 14:00 – approx. 15:30 (CET) About the webinar …

Event details
Event - 3rd November 2022

Technology Patent Network Conference 2022

HGF is a gold sponsor of the Technology Patent Network Conference on Thursday 3rd November 2022 in San Jose. This conference looks at bringing together the industry’s most innovative companies …

Event details
Event - 10th-11th October 2022

IIPLA Conference 2022

IIPLA 2022 USA is a two-day conference event taking place in Las Vegas on 10-11 October. Experts on Intellectual Property will share the stage to share fresh perspectives, data-driven approaches, …

Event details
See all updates

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.

Contact us